I graduated in Biology and Biochemistry at the University of Salamanca and I completed a PhD programme at the Spanish National Cancer Research Centre (CNIO) in Madrid in the Molecular Cytogenetics Group where I developed different research projects in haematological malignancies. Since August 2015, I work as a postdoctoral researcher at the Centre for Haemato-Oncology at Barts Cancer Institute (BCI) of the Queen Mary University of London, identifying and studying the genetic events that lead to the development of familial acute myeloid leukaemia.

I have been a member of SRUK since I arrived to London, actively participating in various events and being part of the Organizing Committee for the 4th International Symposium SRUK/CERU and the SRUK Mentoring Programme.

After my training as a biologist at the Universidad Autonoma de Madrid, I decided to continue doing science and completed a PhD at CNIO (Centro Nacional de Investigaciones Oncológicas) studing the epigenetic modifications on hematological disorders. My next step has been coming to live in Manchester to join the Cancer Research UK – MI as postdoctoral scientist in Tim Somervaille´s lab. I´m fascinating about epigenetics and that´s still my main research focus, with more emphasis in it´s role as putative clinical targets. I joined the Northwest constituency in 2015.

Biosketch: I have a degree Biochemistry awarded by the University of Granada (UG, Spain). While studying my degree, I attended to computer-based biology labs that both delighted me and changed my perspective about the professional career routes in the biomedical field. Influenced by that first approach to computational biology, I carried out a Master in Bioinformatics for Health Sciences, at the University Pompeu Fabra, Barcelona (UPF, Spain) after completing my degrees in 2003. While doing my masters, I had a Research Fellowship at the Molecular Evolution Research Group in the Molecular Biology Institute Barcelona IBMB (CSIC) awarded by La Caixa in 2005. In the master project, I developed a web-interface and an epidemiological database to collect clinical data for a governmental project, IMIDKit, a Genome Wide Association Study of Immune Mediated Diseases. That project was conducted in the Barcelona Supercomputing Center (BSC) where I was hired to maintain and support the project and other projects until 2009. After the completion of the project, I moved to Seville and worked in a system biology project modelling biochemical pathways to optimise the production of ectoines by the organism Chromohalobacter salexigen in the University of Seville (US, Spain). In 2011, I was appointed to a position as a Prostate Cancer (PCa) data manager and data analyst in the Cancer Epidemiology Group in King’s College London (KCL, UK). During the last five years in this role, I have worked to establish the King’s Health Partners PCa Biobank, that currently collects surplus and research only tissue material and data from the PCa patients in Guy’s and St Thomas’ NHS trust (GSTT), and to develop and maintain a GSTT PCa patient’s database for research purposes. Both resources are currently being utilized in different research projects, national and international, where we also participate on the design and analytical phases. In parallel, I am doing a PhD in Biostatistics focus in data reduction methods applied to biomedical data also in King’s College London (KCL, UK), more specifically I have conducted two main studies, a clinical project that aim to study blood serum markers as possible predictors of cancer outcomes and a imaging project that study the feasibility of the usage of a terahertz probe in Breast-conserving surgery to discriminate tumour margins in the operating theatre.

 I graduated in Biochemistry (Hons) at the Complutense University of Madrid. Then I was awarded a PhD Fellowship by the Instituto de Salud Carlos III (Spanish Ministry of Health) to carry out my PhD studies under the supervision of Prof María Antonia Lizarbe and Dr Javier Turnay (Dept. Biochemistry and Molecular Biology I, Complutense University of Madrid). I obtained my PhD degree in Biochemistry and Molecular Biology (Doctor Europeus Mention) for studying the role of 4F2hc in tumorigenesis and the effect on butyrate and bile acids on human colon adenocarcinoma cells. During my PhD, I also did a 6-month internship in Dr Robert Clarke’s group at The University of Manchester (United Kingdom), where I became interested in breast cancer stem cells. I moved to Manchester in August 2013, and since then I have held a postdoctoral position in Dr Robert Clarke’s group. In January 2014, I was awarded a 2-year Postdoctoral Fellowship by the Alfonso Martín Escudero Foundation (Spanish private non-profit institution). More recently, I have been able to secure some funding from Rosetrees Trust and Breast Cancer Now to continue my studies about breast cancer dormancy. In Jan 2015, I joined SRUK/CERU and recently I became part of the Press Office of the Northwest Constituency (February 2016).